After the intervention, MDA of the two groups was decreased while SOD was increased, and MDA of the treatment group was lower than in the control group, and SOD was higher than the control group, suggesting that for gout patients with hyperuricemia, daily treatment with a high dose of 80 mg is of great significance to improve antioxidant ability. This evidence concerns the gene SOD1 and gout.